Simon Wijckmans
← Writing

How to handle hair loss as a male in 2026

The FDA hasn't approved a new drug for pattern hair loss since finasteride in 1997. Spend an hour online and you'll still find shampoos, serums, supplements and clinics all telling you they have the answer. A while back I went down the hair loss rabbit hole properly. There's no silver bullet, and a lot of what's on offer is aimed at the wrong type of hair loss. Below is what I learned.

I'm not a doctor and this isn't medical advice. Anything below that needs a prescription needs a real doctor.

Which type you have

People talk about balding like it's one condition. It isn't, each type needs a different treatment, and in many cases the best you can do is slow the process down.

  • In genetic hair loss, androgenetic alopecia, an enzyme converts testosterone into DHT. DHT binds to receptors in susceptible follicles, and each hair cycle comes back a little finer and shorter until it stops being a real hair. How susceptible you are is mostly inherited, somewhere between 60 and 80 percent by most estimates.

  • There's an old rule of thumb about looking at your mother's father, because the androgen receptor gene sits on the X chromosome and you got your only X from your mother. But of the 600-odd genetic locations mapped so far, only 26 sit on the X. Counting bald relatives on both sides is a better guide.

  • DHT punishes the hair on the top and front of a predisposed scalp, while the back and sides resist it and beard hair gets thicker from it. The follicles at the back and sides stay resistant even after a surgeon moves them to the top of your head, which is why transplants work at all.

A side profile marking the 3 zones: the top and front punished by DHT, the back and sides resistant even after a surgeon moves them, and the jaw where the same hormone thickens hair

  • Stress shedding, telogen effluvium, usually follows a big physiological hit like a high fever, surgery, a rapid drop in weight or a new medication. Because it shows up months later, people miss the connection. It tends to settle once the trigger is gone, though it often exposes pattern loss that was already underway.

  • GLP-1 drugs can do this too. There's now decent evidence linking semaglutide and tirzepatide to shedding, mostly through the rapid weight loss. If you started one and your hair began coming out 4 months later, that's probably not pattern baldness.

  • In alopecia areata, a type of white blood cell attacks the follicle. It mostly shows up as round patches, and a dermatologist diagnoses it by looking at your scalp. There are now 3 approved oral drugs for severe cases, all JAK inhibitors, and many people get most of their hair back on them. They do nothing for pattern baldness. When a news alert says "FDA approves new hair loss drug", it's almost always about this.

  • Iron comes up constantly on hair forums, but nearly all the research on iron and hair is in women, and in men deficiency is much rarer. Get ferritin measured and don't take iron on spec.

What has evidence

  • I think the most useful thing I can pass on is the difference between 4 labels. Approved means a regulator reviewed it for this specific use. Cleared, which is what laser caps are, is a much lower bar. Off-label means the drug is approved, just not for your hair. Compounded means a pharmacy mixed it and nobody reviewed it at all. You'll be sold all 4, often without being told which is which.

  • Minoxidil can help hold follicles in the growth phase if they're still there. It has to land on your scalp, and plenty of people are mostly conditioning their hair with it. Roughly a third of men get regrowth they'd notice in a mirror, and a larger group just gets a slowdown. If you stop, the benefit goes within months.

  • Low-dose oral minoxidil has taken off, and it's the biggest practical change in this field since 2023. It's 1 pill instead of a twice-daily ritual, with an international expert consensus behind it. While that's a big shift, it's still a blood pressure drug used off-label, and no regulator has approved it for hair. That's a conversation to have with a doctor.

  • Finasteride and dutasteride make sense if your loss follows the male pattern: receding temples and a thinning crown. They mostly hold what you have. 83% of men on finasteride had no further loss at 2 years, against 28% on placebo. Give it 6 to 12 months before you judge it, and expect some extra shedding early on. Dutasteride is the stronger of the two, though in the West it's used off-label.

  • Topical finasteride is what people reach for when they're nervous about side effects. In its own trial it still cut circulating DHT by about 35%, against roughly 56% for the tablet. In the US there's no approved topical version, so everything sold there is compounded. The FDA issued a specific alert about that in April 2025.

  • In 2025 European regulators added suicidal ideation as a recognised side effect of finasteride. The UK strengthened its warnings again in May 2026 with mandatory patient alert cards. The drug is still first-line, but any doctor putting you on it should raise this with you, and if your mood changes you stop and you call them.

  • In the registration trials around 3.8% of men on finasteride reported a sexual side effect, against 2.1% on placebo, so the drug adds around 1 or 2 men in 100.

  • Finasteride roughly halves your PSA reading. If you ever get a prostate check, tell your doctor you're on it, because a normal-looking number can be an abnormal one. Both drugs can also harm a male fetus, so broken tablets and topical residue on pillowcases and towels matter if there's any chance of a pregnancy in the house.

  • Laser caps have several double-blind sham-controlled trials showing a real improvement in density. But the trials are short and mostly manufacturer funded, and nothing tells you which of the 30-odd devices is worth buying.

Transplants

  • Once follicles have given up, no drug brings them back. Thinning follicles are still alive though, and they're exactly what finasteride and minoxidil act on. Drugs first and surgery later is almost always the right order.

  • I'd ask about the punch, the blade that cores each follicular unit out of the back of your head. It runs between 0.7 and 1.2mm across, with 0.9mm the usual choice. A wider punch cuts fewer follicles in half but leaves more scarring, and a punch 10% narrower removes about 19% less skin per graft. Go narrow with a mediocre operator and they start slicing through what they're trying to harvest.

Three punches drawn to scale, 0.7mm, 0.9mm and 1.2mm, each around the same follicular unit

  • Transection means follicles cut in half during extraction. In one small study using the same 0.9mm punch with 3 different tips, it ran at 23.9% sharp, 18.8% serrated and 14.5% blunt.

  • A lot of people fly to Turkey, get pushed through a clinic as fast as possible and are back out the same day. I understand why, it's cheaper. I still think it's often a bad setup. 2 British medical tourists died in Istanbul in 2025, and one of those cases was investigated as possible reckless homicide. The international hair restoration society estimates that 15 to 20% of Istanbul clinics aren't properly licensed. While there are good surgeons in Turkey, be careful who you pick.

  • Ask who physically does the extraction and cuts the sites. The same society says harvesting, hairline design and site creation are the doctor's job. In the clinics it warns about, a technician does all 3. I'd want a doctor who can tell you their own transection rate without going to check.

  • Your donor area is finite, so don't treat the first transplant as a cheap experiment. Surgeons want you past about 25 with stable loss, because a Norwood 2 at 22 can be a Norwood 5 at 35.

The same head at Norwood 2 and at Norwood 5, 13 years apart

  • A transplant doesn't get you off the medication. Transplanted follicles are DHT resistant, but the native hair around them isn't. If you stop finasteride, you end up with an island of hair and a gap behind it.

  • If the hairline is a straight ruler edge, if there's no soft feathered transition, or if there are multi-hair grafts in the front row, you'll end up looking like a Playmobil character.

Two hairlines: one a ruled straight line with identical 3-hair grafts on a grid, the other with no line at all, single hairs in front thinning forward

What's coming

  • Clascoterone, a topical that blocks the androgen receptor in the scalp, finished phase 3 trials in late 2025 and would be the first new mechanism in 30 years. It hasn't been filed with the FDA yet, so realistically it's 2027 or 2028 before you could buy it.

  • Hair cloning is further away than it was in 2023. Stemson shut down in December 2024, dNovo has gone quiet and RepliCel delisted. People have been saying regenerative hair is 5 years out for a decade.

If you're worried about hair loss, work out what's causing it before you spend money on anything. If the damage is already done, a transplant by someone who knows exactly what they're doing is sometimes the only lasting answer.